Introduction {#sec1}
============

The gastrointestinal tract is an important site of interactions between the host and the external environment. An intact epithelium forms the first line of host defense against numerous mechanical, chemical, and microbial-driven attacks and rapidly self-renews as a mechanism to maintain homeostasis ([@bib2; @bib12]). This regeneration and replacement of cells is driven by tissue-restricted adult stem cells located at the base of the crypt. These cells undergo largely symmetric divisions, which upon competitive displacement from contact with a Paneth cell niche in the small intestine, stochastically generate a larger pool of more rapidly dividing progenitor cells referred to as transit-amplifying (TA) cells ([@bib16]). A Paneth-like cell fulfills a similar function in the colon. In the small intestine, the TA cells give rise to four terminally differentiated cell types: enterocytes, goblet cells, enteroendocrine cells, and Paneth cells. Two opposing models, the +4 model and the crypt base columnar (CBC) cell model, describe the exact location and identity of intestinal stem cells. The +4 model was based on the presence of slowly cycling, radiation-sensitive cells at the fourth cell position from the bottom of the crypt that showed label retention of BrdU ([@bib11]). However, other studies suggested that the slender, immature, cycling cells wedged between the Paneth cells, i.e., the CBC cells, are stem cells ([@bib4]). The "stemness" of these populations was later established based on their ability to self-renew over long periods of time and produce all differentiated cell types of the intestinal epithelium ([@bib1; @bib14]). Still, the characterization of functional markers in these stem cell populations will likely contribute to our understanding of the response to crypt injury.

Inhibitor of DNA binding 1 (ID1) facilitates cell-cycle progression, inhibits differentiation in multiple cell types, and plays an essential role in the self-renewal of stem cells ([@bib6]). It is sufficient for maintaining murine embryonic stem cell self-renewal and pluripotency in the absence of bone morphogenic protein ([@bib19]), and maintains embryonic stem cell self-renewal by upregulation of Nanog and repression of Brachyury expression ([@bib13]). Loss of *Id1* function leads to premature withdrawal of neuroblasts from the cell cycle and inappropriate expression of neural-specific markers, in addition to a defect in angiogenesis in the murine embryonic brain ([@bib7]). High levels of *Id1* expression define a subpopulation of GFAP+ cells in the subventricular zone (SVZ) of adult mouse brain that are bona fide B1-type adult neural stem cells ([@bib9]) and intermediate levels of Id1 are associated with the more committed progenitor C cells in the SVZ. In addition, this hierarchy is maintained during gliomagenesis ([@bib3]). Therefore, we hypothesized that ID1 might be a fate determinant of other adult stem cell populations.

Here, we show that (1) ID1 expression in the gut is restricted to CBC cells and the +4 position, which corresponds to cells expressing LGR5 and BMI1, respectively, as well as TA cells; (2) these ID1+ cells are self-renewing, multipotent stem cells that are responsible for the long-term renewal of the gut epithelium in lineage-tracing experiments; (3) single *Id1*+ cells efficiently generate long-lived organoids resembling mature intestinal epithelium; and (4) knocking out *Id1* in intestinal epithelial cells impairs LGR5+ stem cell function and sensitizes animals to chemical-induced injury to the colon.

Results and Discussion {#sec2}
======================

Restricted Expression of ID1 at the Base of the Intestinal Crypts {#sec2.1}
-----------------------------------------------------------------

We examined expression of ID1 in the intestine using a highly specific rabbit monoclonal anti-Id1 antibody ([@bib10]). ID1 expression throughout the small intestinal epithelium of adult mice is confined to the crypts, whereas the villi are negative ([Figure 1](#fig1){ref-type="fig"}A). ID1 is expressed in CBC cells interspersed between Paneth cells, +4 position cells, and TA cells ([Figure 1](#fig1){ref-type="fig"}B). The frequency of ID1 positivity is greatest in the +4 to +10 position, with less frequent expression in CBC cells and the higher TA zone ([Figure S1](#app2){ref-type="sec"}A available online). A similar pattern is seen in the mouse colon: ID1+ cells are confined to the bottom two-thirds of the crypt, and the upper, more differentiated part of the crypt and the surface epithelial cells rarely express ID1 ([Figures 1](#fig1){ref-type="fig"}C and 1D). In both the small intestine and the colon, Id1 is present in every crypt ([Figures 1](#fig1){ref-type="fig"}A and 1C). Ki67, a marker of proliferation, and ID1 colocalize in the majority of cells in the crypts of the small intestine and colon ([Figure S2](#app2){ref-type="sec"}). In human small intestine and colon, CBC cells, +4 position cells, and TA cells are positive for ID1 ([Figures 1](#fig1){ref-type="fig"}E--1H). Low levels of ID1 are also found in endothelial cells in normal mouse and human intestine. Costaining for EGFP and ID1 in *Lgr5-EGFP-IRES-creERT* knockin mice demonstrates ID1 immunoreactivity in LGR5+ stem cells ([Figure 1](#fig1){ref-type="fig"}I). Many CBC cells that are positive for *Lgr5-EGFP* also express ID1 protein, and some lacking Id1 are also observed. Consistently, +4 position cells and some early TA cells that are negative for *Lgr5-EGFP* are positive for ID1. Collectively, these observations indicate that ID1 is a stem/progenitor cell marker in both mouse and human colon and small intestine.

ID1+ Cells Support the Renewal of Intestinal Epithelium over Extended Periods {#sec2.2}
-----------------------------------------------------------------------------

To study the potential of ID1+ cells to give rise to more differentiated progeny, we crossed the *Id1-IRES-creERT2* mouse strain ([@bib9]) with animals bearing the *Cre*-activatable *Rosa26-lox-stop-lox-lacZ* allele. Tamoxifen activates the CreERT2 fusion enzyme in *Id1*-expressing cells, and Cre-mediated excision of the roadblock sequence in the *Rosa26-lacZ* reporter permanently marks *Id1*+ cells and their progeny. After a single tamoxifen pulse, adult mice were sacrificed at 0.5, 1, 3, 7, 30, 60, 180, and 365 days after induction ([Figure 2](#fig2){ref-type="fig"}A). LacZ activity is first observed in isolated ID1+ cells at the base of the intestinal crypts 0.5 days postinduction. Approximately 25% of the crypts are labeled at this time (compared with 100% by immunohistochemistry \[IHC\]), likely reflecting incomplete recombination at the *Rosa26* locus, which has also been observed in other cell types ([@bib9]). Among the labeled crypts, 46% show evidence of LacZ expression in the stem cell zone and 34% show expression in the TA cell zone ([Figure 2](#fig2){ref-type="fig"}B, left). The remaining 20% of the labeled crypts exhibit LacZ+ cells in both zones. Among the 46% stem cell zone-labeled crypts, more than half (54%) show LacZ staining at the +4 position, one-third (33%) show LacZ+ CBC cells, and 13% show staining in both populations ([Figure 2](#fig2){ref-type="fig"}B, right). Quantitative analysis of the earliest LacZ+ cells indicates that the CBC and +4 position cells have the highest *Id1* promoter activity ([Figure S1](#app2){ref-type="sec"}B). From day 1 to day 30, there is a continual increase in the number of cells labeled per crypt in both the small intestine and colon ([Figure 2](#fig2){ref-type="fig"}A). Ribbons of cells emanate from the base of the crypt and over time label all epithelial cells in the small intestine ([Figure 2](#fig2){ref-type="fig"}A, top) and colon ([Figure 2](#fig2){ref-type="fig"}A, bottom). For each time point, we analyzed 200 well-oriented crypts in the proximal small intestine to determine the percentage of crypts containing LacZ+ cells. After 0.5, 1, 3, 7, 30, 60, 180, and 365 days, 26.1%, 30.6%, 36.1%, 27.7%, 22.6%, 14.4%, 8%, and 7% of the crypts, respectively, are LacZ+ ([Figure 2](#fig2){ref-type="fig"}C). This reduction over time likely reflects the presence of crypts labeled largely in the *Id1*+ TA population. More than 80% of the crypts labeled at 180 and 365 days are completely labeled as a result of the marking of long-term self-renewing *Id1*+ populations ([Figure 2](#fig2){ref-type="fig"}D). Animals treated with corn oil vehicle control show no LacZ staining at any time point (data not shown).

To demonstrate the multipotency of the ID1+ stem cells, we performed double staining with differentiated cell markers for goblet cells, Paneth cells, enteroendocrine cells, and enterocytes in intestines following tamoxifen treatment. Paneth cells, periodic acid-Schiff (PAS)-positive goblet cells ([Figure 2](#fig2){ref-type="fig"}E), chromogranin A-positive enteroendocrine cells ([Figure 2](#fig2){ref-type="fig"}F), and alkaline phosphatase-positive enterocytes ([Figure 2](#fig2){ref-type="fig"}G) are all present in the LacZ-stained clones on day 30 after tamoxifen induction. In contrast, ID1+ stem/progenitor cells at an early time point (1 day after induction) do not express any of the differentiation cell markers ([Figures 2](#fig2){ref-type="fig"}H--2J). Taken together, these results indicate that ID1 marks the stem cells of the small intestine and colon, which are capable of long-term self-renewal and generate all cell types of the epithelium.

Single Adult *Id1+* Stem Cells Form Crypt-Villus Structures in Vitro {#sec2.3}
--------------------------------------------------------------------

To determine whether *Id1*+ cells are able to generate stable self-renewing intestinal epithelium organoids in vitro, we isolated *Id1*-expressing populations by flow cytometry using an *Id1*^*VenusYFP*^ knockin allele (*Id1*^*v/v*^) ([@bib9]) and cultured them as described previously ([@bib15]; [Figure 3](#fig3){ref-type="fig"}A). Small cyst-like structures were visible after 2--3 days. After 6 days of culture, continuous budding events started and dead cells appeared inside the lumen ([Figure 3](#fig3){ref-type="fig"}B). After 10--14 days, the organoids were dissociated mechanically and replated to form multiple new organoids. This procedure could be repeated every 10--14 days for at least ten passages, and the organoids did not display apparent morphological differences. Single *Id1*^*Venus+*^ cells gave rise to cyst-like organoids (day 4) at an average efficiency of 8%--10%; however, fully formed organoids with a well-organized central lumen (villus domain) and crypt domain were rarely observed (0.1% efficiency). No single sorted *Id1*^*Venus−*^ cells were able to form organoids and they typically died 1 day after plating. The organoids derived from single *Id1*^*Venus+*^ cells gave rise to the four postmitotic differentiated cell types of the small intestine epithelium, as evidenced by positive staining with PAS (Paneth and goblet cells), Alcian blue (goblet cells; [Figures 3](#fig3){ref-type="fig"}C and 3D), the expression of chromogranin A (enteroendocrine cells; [Figure 3](#fig3){ref-type="fig"}E), and positive staining of alkaline phosphatase (enterocytes) ([Figure 3](#fig3){ref-type="fig"}F). These data indicate that single *Id1*+ cells have the capacity to function as multipotent intestinal stem cells in vitro.

Loss of *Id1* Sensitizes Mice to Colitis {#sec2.4}
----------------------------------------

We next determined whether ID1 was required for mucosal homeostasis. Previous analyses suggested that the effects of loss of individual *Id* family members are only observed when stem cells are challenged by tissue damage or progenitor cell killing ([@bib5; @bib9]). Treatment of wild-type mice with dextran sodium sulfate (DSS) induces colitis that mimics clinical and histological features of human ulcerative colitis ([@bib18]). Treatment of wild-type mice with DSS led to an increase in ID1 expression in the colonic epithelium ([Figure S3](#app2){ref-type="sec"}). *Id1* knockout mice and wild-type controls were treated with DSS for 7 days followed by 14 days of plain drinking water. A higher percentage of *Id1*^*−/−*^ mice had severe diarrhea and bleeding compared with wild-type controls upon DSS exposure ([Figures 4](#fig4){ref-type="fig"}A and 4B). *Id1*^*−/−*^ mice also had shorter colons and worse histology scores characterized by loss of crypt structure, ulceration, and infiltration of inflammatory cells ([Figures 4](#fig4){ref-type="fig"}C--4E). All *Id1*^*−/−*^ mice died, whereas nearly all of the wild-type control mice survived ([Figure 4](#fig4){ref-type="fig"}F).

To determine whether the worse colitis observed in *Id1*^*−/−*^ mice reflected an epithelial defect, we generated intestinal epithelium-specific *Id1* knockout (*Id1*^*ΔIEC*^) mice by crossing *Id1*^*fl/fl*^ mice ([@bib9]) with *B6.SJL-Tg(Vil-cre)997Gum/J* transgenic mice, which express Cre recombinase under the direction of the mouse *villin* promoter. *Villin* is broadly expressed in every cell of the intestinal epithelium ([@bib8]). The deletion of ID1 in the unperturbed gut epithelium was continuous and complete ([Figure S4](#app2){ref-type="sec"}). *Id1*^*ΔIEC*^ mice are viable, fertile, normal in size, and do not display any gross physical or behavioral abnormalities. In the absence of injury, deleting *Id1* from epithelial cells has no effect on the morphology of the small intestine or colon. Moreover, no difference in the crypt/villus ratio or crypt fission in control versus *Id1*^*ΔIEC*^ mice was observed (data not shown), suggesting compensation by other ID family members under normal physiological conditions. We then evaluated both the severity of colitis and mortality in *Id1*^*ΔIEC*^ mice. Similar to what was observed in *Id1*^*−/−*^ mice, *Id1*^*ΔIEC*^ mice exhibited more severe colitis, including worse diarrhea and bleeding, shorter colons, and worse histology scores compared with *Id1*^*fl/fl*^ mice ([Figures 4](#fig4){ref-type="fig"}G--4K). Sixty percent of *Id1*^*ΔIEC*^ mice died, whereas all animals in the *Id1*^*fl/fl*^ control group survived ([Figure 4](#fig4){ref-type="fig"}L). No difference in any of these parameters was observed between *Id1*^*fl/fl*^ and *Vil-cre-Id1*^*+/+*^ mice, indicating that Cre recombinase expression per se is not responsible for the observed phenotypes. The fact that both the severity of colitis and mortality increase when *Id1* is knocked out completely versus only in epithelial cells suggests that endothelial Id1 may also be involved in the pathophysiology of colitis.

Next, crypts were isolated from the intestines of wild-type and *Id1*^*−/−*^ mice, and crypt organoid formation and survival were assessed in vitro. In this culture system, 66.6% ± 5.7% of the intestinal crypts isolated from wild-type mice were able to survive, compared with 43.1% ± 11.2% from the *Id1*^*−/−*^ mice (p \< 0.01; [Figures 4](#fig4){ref-type="fig"}M and 4N). The defect observed in the *Id1*^*−/−*^ crypts under harsh culture conditions may be reflective of the suboptimal response to injury in the crypts of *Id1*-deficient mice following DSS treatment.

To evaluate whether ID1 is essential for stem cell function within the crypt, we specifically knocked out *Id1* in Lgr5+ cells by tamoxifen induction in *Lgr5*^*CreER/+*^*;Id1*^*fl/fl*^ mice, which we generated by crossing *B6.129P2-Lgr5*^*tm1(cre/ERT2)Cle*^*/J* and *Id1*^*fl/fl*^ mice. Although EGFP was expressed uniformly in the crypts of the proximal small intestine, expression was variegated in the distal small intestine and colon, as previously described (The Jackson Laboratory, stock number 008875 database). Approximately 40% of the crypts in the colon expressed EGFP, and ID1 was concomitantly deleted in these crypts after tamoxifen administration ([Figure 4](#fig4){ref-type="fig"}O). Failure to observe significant differences in the subjective clinical measurements (diarrhea and bleeding) is likely a consequence of incomplete deletion of *Id1* in the colonic stem cells. Nonetheless, similar to what was observed in the *Id1*^*−/−*^ and *Id1*^*ΔIEC*^ models, DSS treatment led to shorter colons and increased mortality when *Id1* was deleted in the *Lgr5* compartment (*Id1*^*ΔLgr5*^) ([Figures 4](#fig4){ref-type="fig"}P and 4Q).

To begin to explore the mechanism by which *Id1* loss sensitizes the colon to injury, we focused on the expression of genes implicated in mitotic progression. ID1 is important for proliferation in stem and progenitor cells in other tissue types ([@bib9]) and proliferation defects have been observed in the colonic epithelium in the DSS model of colitis ([@bib17]). Hence, we reasoned that loss of *Id1* might sensitize the mice to DSS-induced colonic injury because of an exacerbation of this proliferative defect. We examined the effects of *Id1* loss in colonic epithelium compared with wild-type controls in the absence and presence of DSS treatment for 3 days. Strikingly, 10 of 12 genes implicated in mitotic progression were suppressed significantly in the *Id1* deletion strain in the presence of DSS relative to the other three groups ([Table S1](#app2){ref-type="sec"}). By contrast, the loss of *Id1* in the epithelium in the absence of DSS led to a statistically significant reduction in the expression of only 3 of 12 genes. These results are consistent with the notion that *Id1* loss has the most profound effect on proliferation in the presence of injury. This could be a consequence of a reduced number of stem cells. Further work will be needed to explore this possibility.

Conclusions {#sec2.5}
-----------

Taken together, our results demonstrate that ID1 is not only a marker of adult intestinal stem/progenitor cells but is also important for their function. The current findings suggest a potential role for ID1 agonists in the management of colitis or possibly radiation enteritis. Future studies should explore the mechanism of how ID1 controls intestinal stem cell function and the role of these ID1+ stem/progenitor cells in colitis-related tumor development.

Experimental Procedures {#sec3}
=======================

Mice {#sec3.1}
----

Inbred male mice (8--10 weeks old) were used. Generation and genotyping of *Id1-IRES-CreERT2*, *Id1*^*v/v*^, *Id1*^*−/−*^, and *Id1*^*fl/fl*^ mice have been described previously ([@bib9]). Inbred C57BL6/J mice were used as wild-type controls in experiments utilizing *Id1*^*−/−*^ mice in a C57BL6/J background. *Lgr5-EGFP-IRES-CreERT2*, *Rosa26-LacZ*, and *B6.SJL-Tg (Vil-cre) 997Gum/J* mice were obtained from The Jackson Laboratory.

Tamoxifen Induction {#sec3.2}
-------------------

Mice (8--10 weeks old) were injected intraperitoneally with 200 μl tamoxifen in corn oil at 10 mg/ml.

DSS Colitis Model {#sec3.3}
-----------------

Mice were treated with 3% DSS (molecular weight 36,000--50,000; MP Biomedicals) for 7 days unless otherwise noted and then switched to tap water for the remainder of the experiment. Clinical scores (diarrhea and bleeding) and histology were determined according to standard procedures ([@bib18]) in blinded studies. The animal protocol was approved by the Institutional Animal Care and Use Committee at Memorial Sloan-Kettering Cancer Center.

Histochemistry, IHC, and Immunofluorescence {#sec3.4}
-------------------------------------------

Small intestines and colons were fixed in 4% paraformaldehyde overnight at 4°C. Anti-ID1 (Biocheck), anti-GFP/YFP (Invitrogen), anti-Ki67 (Vector Labs), and anti-chromogranin A (Abcam) antibodies were used. LacZ staining was performed as previously described ([@bib1]). PAS (Sigma-Aldrich), Alcian blue (Dako), and alkaline phosphatase (Thermo Scientific) staining was performed according to the manufacturers' protocols. The intensity of ID1 staining was determined by a gastrointestinal pathologist (R.K.Y.) who was blinded to the treatment group. Human tissues were analyzed under a protocol that was approved by the Weill Cornell Medical College Institutional Review Board.

Crypt Analysis {#sec3.5}
--------------

Crypt isolation, cell dissociation, and culture were performed as described previously ([@bib15]).

Flow Cytometry {#sec3.6}
--------------

Venus (YFP)+ and Venus-- cells were sorted with an Aria flow cytometer (Becton Dickinson Biosciences). Single viable epithelial cells were gated by forward scatter, side scatter, and pulse-width parameter, and by negative staining for DAPI.

Quantitative Real-Time PCR {#sec3.7}
--------------------------

RNA was isolated from whole colon using the RNeasy mini kit and poly A RNA was prepared with an Oligotex mRNA mini kit (QIAGEN). Poly A RNA was reversed transcribed using murine leukemia virus reverse transcriptase and oligo (dT)~16~ primer. The resulting cDNA was used for amplification using the primers listed in [Table S2](#app2){ref-type="sec"}. *Glyceraldehyde 3 phosphate dehydrogenase* (*Gapdh*) was used as a normalization control. Real-time PCR was performed using 2× SYBR Green PCR Master Mix on a 7500 Real-Time PCR System (Applied Biosystems). Gene transcript levels were calculated using the ΔΔCt method.

Statistics {#sec3.8}
----------

A generalized linear mixed-effects model was used to evaluate differences in the probability of having severe diarrhea (diarrhea score \> 2) between experimental groups. A linear mixed-effects model was used to compare average bleeding scores across experimental groups, taking into account both between- and within-mouse variations in the endpoints. The nonparametric Wilcoxon rank-sum test was used to examine differences between two experimental groups in various endpoints, including colon length, histology scores, and percentage of viable organoids. Fisher's exact test was used to compare the distributions of the ordinal IHC staining intensity between control and experimental mice. To compare differences in survival between mice in two experimental groups, the log rank test was used.

Supplemental Information {#app2}
========================

Document S1. Figures S1--S4 and Tables S1 and S2Document S2. Article plus Supplemental Information
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![ID1 Is Detected in Stem and TA Cells in the Small Intestine and Colon\
(A and B) Expression of ID1 protein in wild-type murine small intestine was detected using a rabbit monoclonal ID1 antibody. In (B), high-magnification IHC (left) and immunofluorescence (right) show ID1 immunoreactivity in the TA cells, +4 position cells, and CBC cells.\
(C and D) Low (C) and high (D) magnification IHC of ID1 in crypts of the colon.\
(E and F) Expression of ID1 protein in normal human small intestine was detected by IHC using the rabbit monoclonal ID1 antibody. In (F), high-magnification IHC shows ID1 immunoreactivity in TA cells, +4 position cells, and CBC cells as indicated.\
(G and H) Low (G) and high (H) magnification IHC of ID1 in crypts of the human colon. In (B), (D), (F), and (H), \[ marks TA cells, ![](fx1.gif) marks +4 position cells, and ^∗^ marks CBC cells.\
(I) Colocalization of LGR5 and ID1 in mouse small intestine (left) and colon (right) by EGFP and ID1 staining in *Lgr5-EGFP* mice. ^∗^, CBC cells double positive for EGFP and ID1; ![](fx2.gif), CBC cells positive for EGFP but negative for ID1; ![](fx1.gif), +4 position cells only positive for ID1. Scale bars, 50 μm.\
See also [Figures S1](#app2){ref-type="sec"} and [S2](#app2){ref-type="sec"}.](gr1){#fig1}

![ID1 Labels Long-Term Repopulating Stem Cells in the Small Intestine and Colon\
(A) LacZ staining of small intestine and colon from *Id1-IRES-creERT2/Rosa26-lacZ* mice from 1 day to 1 year after tamoxifen injection.\
(B) Distribution of LacZ+ cells 12 hr after tamoxifen induction. Results are depicted as the means of three independent stretches of proximal small intestine, with ∼50 positive crypts each. The distribution of LacZ+ cells within the stem cell compartment is indicated in the pie chart on the right.\
(C) Frequency of LacZ+ crypts/villi in the proximal small intestine at different time points after tamoxifen induction.\
(D) Percentage of LacZ+ crypts that were completely labeled at different time points. For (C) and (D), ∼200 crypts in each proximal small intestine from three mice were analyzed at all time points. Values are presented as the mean ± SD.\
(E--G) Double labeling of LacZ-stained small intestine by PAS (E), chromogranin A (F), and alkaline phosphatase (G) in LacZ+ clones 30 days after tamoxifen induction. ^∗^, goblet cells; ![](fx3.gif), Paneth cell; ▲, enteroendocrine cell; ↑, enterocyte.\
(H--J) Same as (E)--(G), but 1 day after tamoxifen induction. Note that double labeling was not observed. Scale bars, 50 μm.](gr2){#fig2}

![Single *Id1+* Cells Generate Crypt-Villus Structure\
(A) Flow-cytometric analysis of *Id1*^*venus+*^ epithelial cells from an *Id1*^*v/v*^ small intestine. Gate was based on negative control from C57BL/J intestine epithelial cells.\
(B) Example of time-dependent organoid formation from a single *Id1*^*venus+*^ cell over a period of 10 days. Arrows mark defects in culture plastic that were used as "landmarks" to track individual cells through early developmental phases to a mature organoid. Scale bar, 50 μm.\
(C--F) Paraffin sections from single *Id1*^*venus+*^ cell-derived organoids stained with PAS (C, ^∗^, goblet and Paneth cells), Alcian blue (D, ![](fx3.gif), goblet cells), chromogranin A antibody (E, ▲, enteroendocrine cells), and NBT/BCIP for alkaline phosphatase (F, ↑, enterocytes). NS, nonspecific staining. Scale bars, 50 μm.](gr3){#fig3}

![*Id1* Deficiency Sensitizes Mice to Worse Experimental Colitis\
(A--F) Complete *Id1* knockout.\
(A--D and F) Mice were given 3% DSS (w/v) for 7 days followed by 14 days of plain drinking water. Severity of diarrhea, n = 6/group (A); bleeding, n = 6/group (B); colon length, n = 10/group (C); histology score, n = 10/group (D); and mortality over time, n = 13/group (F) were recorded.\
(E) Representative histology (H&E staining) demonstrating worse injury in *Id1*^*−/−*^ mice. The percentage of mice with severe diarrhea was calculated for the surviving mice in each group at each time point. The mean ± SEM for fecal blood score was determined for the surviving mice in each group at each time point. Colon length and histology score were measured in mice at the time of sacrifice on day 8 and summarized in box-and-whisker plots.\
(G--L) Id1 deletion in epithelial cells.\
(G--J and L) *Id1*^*fl/fl*^ and *Id1*^*ΔIEC*^ mice were given DSS for 7 days followed by 14 days of plain drinking water. Severity of diarrhea, n = 6/group (G); bleeding, n = 6/group (H); colon length, n = 4--11/group (I); histology score, n = 4--11/group (J); and mortality over time, n = 10--11/group (L) were recorded.\
(K) Representative histology (H&E staining) demonstrates worse injury in *Id1*^*ΔIEC*^ mice. The percentage of mice with severe diarrhea was calculated for the surviving mice in each group at each time point. The mean ± SEM for fecal blood score was determined for the surviving mice in each group at each time point. Colon length and histology score were measured in mice that survived until day 21 and described using the box-and-whisker plots.\
(M and N) Effect of *Id1* depletion on organoid formation and survival.\
(M) Intestinal crypts were dissociated from wild-type and *Id1*^*−/−*^ mice (n = 5/group) and plated in Matrigel, and 24 hr later the fraction of viable organoids was assessed and summarized using the box-and-whisker plot. Thirty 40× microscopic fields were analyzed for each group.\
(N) Representative images of crypt organoid populations from wild-type and Id1^−/−^ mice.\
(O--Q) Effect of *Id1* depletion in stem cells.\
(O) Depletion of *Id1* in *Lgr5*^*EGFP-IRES-CreERT2;Id1fl/fl/+*^ (*Id1*^*ΔLgr5*^) colon after tamoxifen induction. Note that crypts with high *Lgr5* expression (green) are devoid of *Id1* (red).\
(P and Q) *Id1*^*fl/fl*^ and *Id1*^*ΔLgr5*^ mice were given DSS for 7 days followed by 14 days of plain drinking water. Colon lengths were compared (n = 9/group; P) on day 8 and summarized using the box-and-whisker plot, and mortality over time (n = 29/group; Q) was recorded. Scale bars, 50 μm.\
See also [Figures S3](#app2){ref-type="sec"} and [S4](#app2){ref-type="sec"}.](gr4){#fig4}
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